Throughout its 300-year history,
ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.
A history of 300 years
History
Founding
Founding of the Apothecary “Fushimiya Ichibei” (Fushi-Ichi)
- 1717
- The first Ichibei Ono set up the apothecary “Fushimiya Ichibei” in Doshomachi, Osaka.
- 1934
- Reorganized to an unlimited partnership, and changed the name to “Ono Ichibei Shoten”.
1947
Transition from Ono Ichibei Shoten to ONO PHARMACEUTICAL
- 1947
- ONO PHARMACEUTICAL CO., LTD. was established.
- 1962
- Listed on the Osaka Securities Exchange.
- 1963
- Listed on the Tokyo Stock Exchange.
1968
Working towards Shifting in Marketing and R&D from OTC Drugs to Prescription Drugs
- 1968
- Completion of the Central Research Institute (Current the Minase Research Institute)
Made a world-first success of total synthesis of prostaglandin (PG) as a public corporation.
- 1975
- Completion of the Fujiyama Plant
- 1978
- Completion of the new head office building (Current the head branch)
- 1982
- The London office was opened in the United Kingdom.
- 1985
- Completion of the Fukui Research Institute for safety assessment
- 1990
- The Seattle office was opened in the United States.
- 1994
- The Seoul office was opened in South Korea (Later Seoul Branch).
- 1995
- Completion of the new building for Tokyo Branch (Current the Tokyo Office)
- 1998
- ONO PHARMA UK LTD. and ONO PHARMA USA, INC. were established.
(The London office and the Seattle office developed into ONO PHARMA UK LTD. and ONO PHARMA USA, INC., respectively.)
- 1999
- Completion of the Fujiyama Plant
2003
Delivering Innovative New Drugs to Patients around the World
- 2003
- The Tsukuba Research Institute was opened.
Completion of the new Head Office building
- 2013
- ONO PHARMA KOREA CO., LTD. was established in South Korea
(The Seoul office developed into ONO PHARMA KOREA., LTD.)
- 2014
- ONO PHARMA TAIWAN CO., LTD. was established in Taiwan.
- Launched the world's first anti-PD1 antibody, OPDIVO Intravenous Infusion, in Japan.
- 2016
- Completion of the new Research Building (The Third Building) in the Minase Research Institute
- 2018
- Completion of the Tokyo Building
- 2019
- Completion of the Yamaguchi Plant
- 2020
- Ono Venture Investment, Inc. was established in the United States.
Ono Venture Investment Fund I, L.P. was established in the United States.
- 2021
- Ono Pharma Healthcare Co., Ltd. was established.
- 2022
- Closure of the Fukui Research Institute. (It's functions were consolidated into the Minase Research Institute.)
Ono Digital health Investment, GK was established.
Ono Pharma UD Co., Ltd. was established.
michiteku Co., Ltd. was established.
- 2023
- OPhrs Co., Ltd. was established.
- 2024
- Ono acquired Deciphera Pharmaceuticals, Inc., a US biopharmaceutical compnay.